A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment

Published:2020-08-07 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Zhang Wei,Shen Yimin,Huang Huanhuan,Pan Sheng,Jiang Jingxin,Chen Wuzhen,Zhang Ting,Zhang Chao,Ni Chao

Funder

Natural Science Foundation of Zhejiang Province

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference167 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin.,2020

2. Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer;Schmid;N Engl J Med.,2018

3. Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study;Schmid;Ann Oncol,2020

4. Pembrolizumab for early triple-negative breast cancer;Schmid;N Engl J Med.,2020

5. Regulatory T cells control the switch from in situ to invasive breast cancer;Martinez;Front Immunol.,2019

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review concerning the breast cancer-related tumour microenvironment;Critical Reviews in Oncology/Hematology;2024-07

2. Bioinformatic analysis and experimental validation of six cuproptosis-associated genes as a prognostic signature of breast cancer;PeerJ;2024-06-18

3. Effect of physical exercise on immune, inflammatory, cardiometabolic biomarkers, and fatty acids of breast cancer survivors: results from the MAMA_MOVE Gaia After Treatment trial;Supportive Care in Cancer;2024-02-21

4. Neutrophils as potential therapeutic targets for breast cancer;Pharmacological Research;2023-12

5. Beyond the horizon: Neutrophils leading the way in the evolution of immunotherapy;Cancer Medicine;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3